TY  - CHAP
M1  - Book, Section
TI  - Sickle Cell Anemia & Related Syndromes
A1  - Damon, Lloyd E.
A1  - Andreadis, Charalambos Babis
A2  - Papadakis, Maxine A.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
A2  - Gandhi, Monica
PY  - 2025
T2  - Current Medical Diagnosis & Treatment 2025
AB  - Key  Clinical  Updates  in  Sickle  Cell  Anemia  &  Related  SyndromesTwo  genetically  engineered  stem  cell  products  used  with  autologous  transplantation,  lovotibeglogene  autotemcel  and  exagamglogene  autotemcel,  are  approved  in  the  United  States  for  patients  12  years  or  older  with  severe  disease  and  offer  the  potential  for  long-term  disease  control.Kanter  J  et  al.  N  Engl  J  Med.  [PMID:  34898139]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2025/07/17
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1209225383
ER  -